Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies
- 5 March 1987
- journal article
- research article
- Published by Elsevier in Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section
- Vol. 68 (2) , 81-87
- https://doi.org/10.1016/0168-5597(87)90035-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Ocular changes in patients undergoing long-term desferrioxamine treatment.British Journal of Ophthalmology, 1984
- Deferoxamine (Desferal®)-induced Toxic Retinal Pigmentary Degeneration and Presumed Optic NeuropathyOphthalmology, 1984
- VISUAL LOSS IN PATIENT ON HIGH-DOSE SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1984
- OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINEThe Lancet, 1983
- Hemi-field pattern reversal visual evoked potentials. I. Normal subjectsElectroencephalography and Clinical Neurophysiology, 1982
- The effect of experimental ‘scotomata’ on the ipsilateral and contralateral responses to pattern-reversal in one half-fieldElectroencephalography and Clinical Neurophysiology, 1978
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Iron chelation therapy with deferoxamine in Cooley anemiaThe Journal of Pediatrics, 1978
- THE PATTERN-EVOKED POTENTIAL IN COMPRESSION OF THE ANTERIOR VISUAL PATHWAYSBrain, 1976
- A paradox in the lateralisation of the visual evoked responseNature, 1976